Who we are
Our Culture
Milestones
Management
Team Capability
Production base
Offices
Cooperation
Omni Pharma completed the D round of hundreds of millions RMB financing, led by Shanghai Healthcare Capital
OMNI Pharma announces the merger with Shanghai SMC Biotechnology Co., Ltd. to accelerate the pace of commercialization
OMNI announced the company has reached an agreement with a major Indian pharmaceutical company to develop an inhalation product in the US and European markets
The first subject was successfully enrolled in the phase III clinical trial of OMNI StarE study
About
Technical
备案号:沪ICP备12031398号-1